Search Results - "Bally, C."

Bivalirudin as an adjunctive anticoagulant to heparin in the treatment of heparin resistance during cardiopulmonary bypass-assisted cardiac surgery by McNair, E, Marcoux, J-A, Bally, C, Gamble, J, Thomson, D

“…Heparin resistance (unresponsiveness to heparin) is characterized by the inability to reach acceptable activated clotting time values following a calculated…”
Get full text

A G polymorphism in the CRBN gene acts as a biomarker of response to treatment with lenalidomide in low/int-1 risk MDS without del(5q) by Sardnal, V, Rouquette, A, Kaltenbach, S, Bally, C, Chesnais, V, Leschi, C, Ades, L, Santini, V, Park, S, Toma, A, Fenaux, P, Dreyfus, F, Fontenay, M, Kosmider, O

Get full text

Results of a Phase II Study of Guadecitabine in Higher Risk MDS Patients Refractory to or Relapsing after Azacitidine Treatment by Sebert, M, Bally, C, Peterlin, P, Beyne-Rauzy, O, Legros, L, Gourin, M.P, Sanhes, L, Wattel, E, Gyan, E, Park, S, Stamatoullas, A, Laribi, K, Banos, A, Jueliger, S, Chevret, S, Ades, L, Fenaux, P

Get full text

Mutational Analysis of MDS and AML Occurring after Treatment for Acute Promyelocytic Leukemia (APL). A Report of 9 Cases by Attias, P, Renneville, A, Thomas, X, Bally, C, Hayette, S, Farhat, H, Eclache, V, Marceau, A, Cassinat, B, Feuillard, J, Terre, C, Delabesse, E, Park, S, Lejeune, S, Chevret, S, Ades, L, Preudhomme, C, Fenaux, P

Get full text

P-006 Prognostic value of TP53 gene mutations in higher-risk MDS treated with azacitidine (AZA) by Bally, C, Ades, L, Renneville, A, Mozziconacci, M.J, Preudhomme, C, DeThé, H, Lehmann-Che, J, Fenaux, P

Get full text

P-023 Incidence and prognostic value of TP53 mutations in IPSS low and INT 1 (lower risk) MDS with del 5q by Bally, C, Ades, L, Renneville, A, Preudhomme, C, Raynaud, S, Cluzeau, T, Eclache, V, Hunault-Berger, M, Stamoullas, A, Fontenay, M, Mozziconacci, M.J, De Thé, H, Fenaux, P, Lehmann-Che, J

Get full text

Le FOUR score en français, un nouveau score d'évaluation de la profondeur du coma by WEISS, N, MUTLU, G, PIERROT-DESEILLIGNY, C, BOLGERT, F, ESSARDY, F, NACABAL, C, SAUVES, C, BALLY, C, HOUBERT, M, LECORRE, C, GERMACK, V, DEMERET, S

Get full text

The French version of the FOUR score: A new coma score by Weiss, N, Mutlu, G, Essardy, F, Nacabal, C, Sauves, C, Bally, C, Houbert, M, Lecorre, C, Germack, V, Demeret, S, Pierrot-Deseilligny, C, Bolgert, F

“…Comatose state is a major cause for admission to the intensive care unit. The most commonly used assessment score is the Glasgow coma scale (GCS). Although…”
Get full text

Prognostic value of TP53 gene mutations in myelodysplastic syndromes and acute myeloid leukemia treated with azacitidine by Bally, Cecile, Adès, Lionel, Renneville, Aline, Sebert, Marie, Eclache, Virginie, Preudhomme, Claude, Mozziconacci, Marie-Joelle, de The, Hugues, Lehmann-Che, Jacqueline, Fenaux, Pierre

“…Abstract TP53 mutations are found in 5–10% of MDS and AML, where they are generally associated with complex karyotype and an overall poor prognosis. However,…”
Get full text

Resistance to Therapy in Acute Promyelocytic Leukemia by Lehmann-Che, Jacqueline, Bally, Cecile, de Thé, Hugues

“…Resistance to treatment in patients with acute promyelocytic leukemia is rare. The authors describe the development of resistance to arsenic through a mutation…”
Get full text

269 - Mutational Analysis of MDS and AML Occurring after Treatment for Acute Promyelocytic Leukemia (APL). A Report of 9 Cases by Attias, P., Renneville, A., Thomas, X., Bally, C., Hayette, S., Farhat, H., Eclache, V., Marceau, A., Cassinat, B., Feuillard, J., Terre, C., Delabesse, E., Park, S., Lejeune, S., Chevret, S., Ades, L., Preudhomme, C., Fenaux, P.

Get full text

85 - Results of a Phase II Study of Guadecitabine in Higher Risk MDS Patients Refractory to or Relapsing after Azacitidine Treatment by Sebert, M., Bally, C., Peterlin, P., Beyne-Rauzy, O., Legros, L., Gourin, M.P., Sanhes, L., Wattel, E., Gyan, E., Park, S., Stamatoullas, A., Laribi, K., Banos, A., Jueliger, S., Chevret, S., Ades, L., Fenaux, P.

Get full text

Eosinophilic pleural effusion related to taking valproic acid by Bally, C, Martin, C, Kraoua, S, Kanaan, R, Lacronique, J, Dusser, D, Burgel, P-R

“…Eosinophilic pleural effusions have multiple aetiologies. We report on the case of a 40-year-old man who experienced an eosinophilic pleural effusion with…”
Get full text

Recurrent Staphylococcus aureus infections by Bally, C, Meyssonnier, V, Bricaire, F

Get full text

Infections récidivantes à Staphylococcus aureus by Bally, C., Meyssonnier, V., Bricaire, F.

Get full text

Une pleurésie à éosinophiles liée à la prise d’acide valproïque by Bally, C., Martin, C., Kraoua, S., Kanaan, R., Lacronique, J., Dusser, D., Burgel, P.-R.

“…Les épanchements pleuraux à éosinophiles ont des causes multiples. Nous rapportons le cas d’un homme de 40 ans qui a développé un épanchement pleural à…”
Get full text

Antibody activation of mutant human fructosediphosphate aldolase B in liver extracts of patients with hereditary fructose intolerance by Gitzelmann, R, Steinmann, B, Bally, C, Lebherz, H G

Get more information

HLA and DRW antigens in insulin-dependent diabetes by de Moerloose, P, Jeannet, M, Bally, C, Raffoux, C, Pointel, J P, Sizonenko, P

Get full text

Recurrent Staphylococcus aureus infections by Bally, C, Meyssonnier, V, Bricaire, F

Get full text

Le FOUR score en français, un nouveau score d’évaluation de la profondeur du coma by Weiss, N., Mutlu, G., Essardy, F., Nacabal, C., Sauves, C., Bally, C., Houbert, M., Lecorre, C., Germack, V., Demeret, S., Pierrot-Deseilligny, C., Bolgert, F.

“…Le coma est une cause fréquente d’hospitalisation en réanimation. Parmi les échelles mesurant sa profondeur, le score de Glasgow (GCS) est le plus utilisé. Ce…”
Get full text